The ability to detect and assess cell-free tumor DNA will keep getting better, ultimately making "liquid biopsy" a standard of early detection and care. A new report @CellCellPress today highlights progress in tDNA sequencing value for a form of lung cancer

→ View original post on X — @erictopol,